The University of Chicago Header Logo

Connection

Mark J. Ratain to Receptors, Interleukin-6

Back to Details
This is a "connection" page, showing publications Mark J. Ratain has written about Receptors, Interleukin-6.
Mark J. Ratain
Connection Strength
0.047
Receptors, Interleukin-6
  1. COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.